--- title: "GUAN CHAO HLDGS has entered into three final agreements, including a trademark licensing agreement; an exclusive authorization agreement with Li Zi; and an exclusive authorization agreement with Jing Tai" description: "GUAN CHAO HLDGS announced on May 26, 2025, that its wholly-owned subsidiary BetaMind Investments Limited has signed three final agreements, including a trademark licensing agreement, an exclusive auth" type: "news" locale: "en" url: "https://longbridge.com/en/news/241841860.md" published_at: "2025-05-26T11:18:12.000Z" --- # GUAN CHAO HLDGS has entered into three final agreements, including a trademark licensing agreement; an exclusive authorization agreement with Li Zi; and an exclusive authorization agreement with Jing Tai > GUAN CHAO HLDGS announced on May 26, 2025, that its wholly-owned subsidiary BetaMind Investments Limited has signed three final agreements, including a trademark licensing agreement, an exclusive authorization agreement with Li Zi, and an exclusive authorization agreement with Jing Tai. The trademark licensing agreement grants BetaMind the right to use trademarks associated with the "Groland" brand, with a validity period of twelve months. The exclusive authorization agreements with Li Zi and Jing Tai grant BetaMind exclusive licenses to use specific compounds globally, both valid for twelve months According to the announcement from Guan Chao Holdings (01872), on May 26, 2025, the company's wholly-owned subsidiary BetaMind Investments Limited (BetaMind) entered into three final agreements, including a trademark licensing agreement; an exclusive authorization agreement with Li Zi; and an exclusive authorization agreement with Jing Tai. On May 26, 2025, BetaMind signed a trademark licensing agreement (the "Trademark Licensing Agreement") with Shenzhen Li Zi Rui Ya. This agreement grants BetaMind and its designated contacts the right to use the target trademark (i.e., trademarks related to the "Groland" brand). According to the terms of the Trademark Licensing Agreement, the license for the target trademark is valid for twelve months from the effective date of the Trademark Licensing Agreement, depending on whether BetaMind pays the initial licensing fee stipulated in the Trademark Licensing Agreement. The licensed area for the target trademark includes the countries or regions where the target trademark is registered. On the same day, BetaMind, Shenzhen Li Zi Rui Ya, and Shenzhen Jing Tai signed an exclusive authorization agreement (the "Li Zi Exclusive Authorization Agreement"). This agreement stipulates that Shenzhen Jing Tai and its affiliates (i.e., Shenzhen Zhong Ge Biotechnology Co., Ltd. (Shenzhen Zhong Ge)) will grant BetaMind exclusive rights (including sublicensing rights) to partially use the target compound XTP-016 in the global application of the cyclic peptide compound CN202311247312.8 (the "XTP-016 License"). The Li Zi Exclusive Authorization Agreement is valid for twelve months from the date of signing. During this period, BetaMind is authorized to engage in research, development, improvement, manufacturing, use, commercialization, sale, offer for sale, export, and import of the target compound XTP-016 and/or related products. In addition to the above, on May 26, 2025, BetaMind signed an exclusive authorization agreement (the "Jing Tai Exclusive Authorization Agreement") with Shenzhen Jing Tai. This agreement stipulates that Shenzhen Jing Tai and its affiliates (i.e., Shenzhen Zhong Ge) will grant BetaMind exclusive rights (including sublicensing rights) to partially use the amino acid carbamate compounds and their derivatives and applications with the cyclic peptide compound CN202311128222.7 in the target compound XTP-018 (the "XTP-018 License"). The Jing Tai Exclusive Authorization Agreement is valid for twelve months from the date of signing. During this period, BetaMind is authorized to engage in research, development, improvement, manufacturing, use, commercialization, sale, offer for sale, export, and import of the target compound XTP-018 and/or related products. The announcement disclosed that the XTP-016 License and XTP-018 License include proprietary technologies and key raw materials that are crucial for formulating hair growth products. These materials serve as the main active ingredients in research and development work. According to the information available to the directors, the compound XTP-018 related to the XTP-018 License is intended for the development and production of second-generation products, while the compound XTP-016 mentioned in the XTP-016 License is designated for the development and production of first-generation products After comprehensive due diligence and strategic business planning, the board believes that entering into such agreements presents valuable opportunities for the Group. These transactions are considered an appropriate way to leverage the relevant value of the target trademarks, XTP-016 licensing rights, and XTP-018 licensing rights. This move will allow the Group to enter promising new business areas, supported by a well-structured business model that integrates artificial intelligence and robotics research and development frameworks, covering production, sales, and distribution planning. Currently, the board is formulating a budget for additional investments aimed at establishing the new business. The proposed budget will cover various key areas, including human resources, production facilities, necessary equipment, sales and marketing plans, promotional activities, contact work, logistics, and raw material procurement. The board is confident that, in the long run, this new business initiative will enhance the Group's sustainable growth capacity and broaden its revenue sources. Therefore, this move is seen as being in the overall best interests of the Company and its shareholders ### Related Stocks - [01872.HK - GUAN CHAO HLDGS](https://longbridge.com/en/quote/01872.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 星展分析师上调评级后 云顶新加坡股价涨逾 3% \| 联合早报网 | 星展集团研究将云顶新加坡的评级上调至 “买入”，目标价为 0.90 元，认为通过回购或发放特别股息等资本回报计划，该股有望提升估值并释放股东价值。云顶新加坡股价上涨 3.25%，报 0.795 元。分析师指出，公司每股净现金超过 0.27 | [Link](https://longbridge.com/en/news/276314423.md) | | 三星、海力士 “调整战略”：新存储工厂生产计划提前 | SK 海力士计划将其龙仁一期晶圆厂的试运行时间提前至明年 2-3 月，三星电子将平泽 P4 工厂的投产时间从明年一季度提前至今年四季度，生产规划前移约三个月。调整源于 AI 数据中心扩张导致供应严重短缺，主要客户需求满足率仅 60%。市场普 | [Link](https://longbridge.com/en/news/276302716.md) | | 加拿大宣布新国防工业战略，注重国内制造以重获战备能力 | 加拿大总理卡尼于 2 月 17 日宣布新的国防工业战略，设定未来十年目标，包括将 70% 的国防合同授予本国企业，旨在实现国内采购和维护大部分军事装备。 | [Link](https://longbridge.com/en/news/276178964.md) | | 百汇生命 REIT 首获星展 7200 万元社会贷款 并拟发行 7000 万元绿色债券 \| 联合早报网 | 百汇生命产业信托（Parkway Life REIT）从星展银行获得 7200 万新元的社会贷款，并计划发行 7000 万新元的绿色债券。这是其首次获得社会贷款和发行绿色债券，符合新推出的可持续融资框架。信托管理公司表示，所获资金将用于再融 | [Link](https://longbridge.com/en/news/276454669.md) | | 美股的 “危险信号” | 本月标普 500 指数成分股在八个交易日内下跌 7% 或以上的股票数量已经超过 100 只，直逼 2022 年美股熊市的水平。 虽然这不像新冠疫情或关税危机期间那样极端，但该指标超过 100 通常意味着更大范围的下滑，而这种情况目前还没有发 | [Link](https://longbridge.com/en/news/276185288.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.